NEW YORK (GenomeWeb) – Becton Dickinson reported a 41 percent year-over-year increase in its fiscal third quarter revenues today, primarily due to the acquisition of C.R. Bard.
For the three months ended June 30, the medical technology company posted $4.28 billion in revenues, up from $3.04 billion during the year-ago quarter and slightly beating average analyst estimates of $4.24 billion.
Revenues from BD's Medical segment were $2.25 billion during the quarter, up 20 percent from $1.87 billion last year, which mainly resulted from the acquisition of C.R. Bard.